电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

ZEBOV GP Protein (AA 33-637) (His tag)

ZEBOV GP 宿主: Ebola Virus 宿主: HEK-293 Cells Recombinant >85 %
产品编号 ABIN6941972
发货至: 中国
  • 抗原 See all ZEBOV GP products
    ZEBOV GP (Zaire Ebola Virus Envelope Glycoprotein (ZEBOV GP))
    蛋白类型
    Recombinant
    产品特性
    AA 33-637
    宿主
    • 5
    • 1
    Ebola Virus
    资源
    • 4
    • 1
    • 1
    HEK-293 Cells
    标记
    This ZEBOV GP protein is labelled with His tag.
    原理
    Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein (GP) protein produced in HEK293 cells. Protein contains a C-terminal 6x His-tag
    特异性
    Recombinant Ebolavirus (subtype Zaire, strain Kikwit-95) Envelope Glycoprotein (GP), comprising amino-acids 33-637. This protein is produced in mammalian cells with greater than 85% purity and incorporates a C-terminal 6x His-tag.
    产品特性
    Ebola Virus Envelope Glycoprotein (GP) (Zaire)
    纯度
    >85 %
  • 说明

    This Ebola virus envelope glycoprotein (GP) contains both GP1 and GP2, in heterodimeric form. It is derived from the GP sequence (Accession # AAQ55048.1), expressing Ile33 – Asp637, and is fused with a polyhistidine tag at the C-terminus. The total calculated MW of Ebola envelope glycoprotein (GP) is 67kDa. The protein is expressed in HEK293 cells, and DTT-reduced protein migrates as two bands of 21-23kDa (GP2) and 110-120kDa (GP1) in SDS-PAGE

    限制
    仅限研究用
  • 状态
    Lyophilized
    缓冲液
    PBS pH 7.4
    储存条件
    4 °C
    储存方法
    4°C
  • 抗原
    ZEBOV GP (Zaire Ebola Virus Envelope Glycoprotein (ZEBOV GP))
    别名
    Ebola Envelope Glycoprotein (GP) (Zaire) (ZEBOV GP 产品)
    物质类
    Viral Protein
    背景
    Ebola hemorrhagic fever (EHF) is a severe disease caused by several species of Ebolavirus (EBOV), in the family Filoviridae. Prior to 2007, four species of EBOV had been identified, with two (Zaire ebolavirus andSudan ebolavirus) having caused significant disease outbreaks in humans. The presence of a fifth EBOV virus species,Bundibugyo ebolavirus (BEBOV) was identified after an outbreak of EHF in the Bundibugyo District of western Uganda in 2007. Outbreaks of EHF are associated with person-to-person transmission after the virus is introduced into humans from a zoonotic reservoir. During outbreaks the virus is commonly transmitted through direct contact with infected persons or their bodily fluids. The onset of EHF is associated with nonspecific signs and symptoms, including fever, myalgias, headache, abdominal pain, nausea, vomiting, and diarrhoea. In the later stages of disease, overt haemorrhage has been reported in up to 50% of cases.
    The Zaire subtype of the Ebola virus family is currently the most important in relation to outbreaks of disease in humans. This subtype has been responsible for the largest ever outbreak of EHF, which started in West Africa in 2014, and was finally declared over only in early 2016. The Kikwit-95 strain was isolated from an outbreak occurring in the city of Kikwit in Zaire in 1995. This outbreak has been especially well studied. There were 314 cases, with 244 fatalities, a mortality rate ofGreater than75%.
    Ebola virus envelope glycoprotein is initially produced as a precursor known as pre-GP, which is cleaved by furin into two subunits, GP1 and GP2, which remain associated through a disulfide linkage between Cys53 of GP1 and Cys609 of GP2. This heterodimer assembles into a 450-kDa trimer at the surface of nascent virions. The virion-attached GP is critical in the EBOV life cycle, as it is solely responsible for attachment, fusion and entry of target cells. Moreover, GP is responsible for critical pathogenic differences among viral species.
    UniProt
    AAQ55048.1
You are here:
客服